Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
BMC Complementary Medicine and Therapies
Published in: BMC Complementary Medicine and Therapies 1/2013

Open Access 01-12-2013 | Research article

In vitro and in vivo antibacterial activities of cranberry press cake extracts alone or in combination with β-lactams against Staphylococcus aureus

Authors: Moussa S Diarra, Glenn Block, Heidi Rempel, B Dave Oomah, Judy Harrison, Jason McCallum, Simon Boulanger, Éric Brouillette, Mariza Gattuso, François Malouin

Published in: BMC Complementary Medicine and Therapies | Issue 1/2013

Login to get access

Abstract

Background

Cranberry fruits possess many biological activities partly due to their various phenolic compounds; however the underlying modes of action are poorly understood. We studied the effect of cranberry fruit extracts on the gene expression of Staphylococcus aureus to identify specific cellular processes involved in the antibacterial action.

Methods

Transcriptional profiles of four S. aureus strains grown in broth supplemented or not with 2 mg/ml of a commercial cranberry preparation (Nutricran®90) were compared using DNA arrays to reveal gene modulations serving as markers for biological activity. Ethanol extracted pressed cakes from fresh fruits also produced various fractions and their effects on marker genes were demonstrated by qPCR. Minimal inhibitory concentrations (MICs) of the most effective cranberry fraction (FC111) were determined against multiple S. aureus strains and drug interactions with β-lactam antibiotics were also evaluated. Incorporation assays with [3H]-radiolabeled precursors were performed to evaluate the effect of FC111 on DNA, RNA, peptidoglycan (PG) and protein biosynthesis.

Results

Treatment of S. aureus with Nutricran®90 or FC111 revealed a transcriptional signature typical of PG-acting antibiotics (up-regulation of genes vraR/S, murZ, lytM, pbp2, sgtB, fmt). The effect of FC111 on PG was confirmed by the marked inhibition of incorporation of D-[3H]alanine. The combination of β-lactams and FC111 in checkerboard assays revealed a synergistic activity against S. aureus including strain MRSA COL, which showed a 512-fold drop of amoxicillin MIC in the presence of FC111 at MIC/8. Finally, a therapeutic proof of concept was established in a mouse mastitis model of infection. S. aureus-infected mammary glands were treated with amoxicillin, FC111 or a combination of both; only the combination significantly reduced bacterial counts from infected glands (P<0.05) compared to the untreated mice.

Conclusions

The cranberry fraction FC111 affects PG synthesis of S. aureus and acts in synergy with β-lactam antibiotics. Such a fraction easily obtained from poorly exploited press-cake residues, may find interesting applications in the agri-food sector and help reduce antibiotic usage in animal food production.
Appendix
Available only for authorised users
Literature
1.
Archer GL: Staphylococcus aureus: a well-armed pathogen. Clin Infect Dis. 1998, 26: 1179-1181. 10.1086/520289.CrossRefPubMed
2.
Seo KS, Bohach GA: Staphylococcus aureus. Food Microbiology: Fundamentals and Frontiers. Edited by: Doyle MP, Beuchat LR. 2007, Washington, DC, USA: ASM Press, 493-518. 3CrossRef
3.
Reyher KK, Dufour S, Barkema HW, Des Coteaux L, Devries TJ, Dohoo IR, Keefe GP, Roy JP, Scholl DT: The National Cohort of Dairy Farms - a data collection platform for mastitis research in Canada. J Dairy Sci. 2011, 94: 1616-1626. 10.3168/jds.2010-3180.CrossRefPubMed
4.
Jordan FTW: Poultry Diseases. 2008, Philadelphia, PA USA: Saunder Elsevir Lte, 191-195. 6
5.
De Kimpe SJ, Thiemermann C, Vane JR: Role for intracellular platelet-activating factor in the circulatory failure in a model of gram-positive shock. Br J Pharmacol. 1995, 116: 3191-3198. 10.1111/j.1476-5381.1995.tb15123.x.CrossRefPubMedPubMedCentral
6.
Donlan RM: Biofilms: microbial life on surfaces. Emerg Infect Dis. 2002, 89: 881-890.CrossRef
7.
8.
Zechini B, Versace I: Inhibitors of multidrug resistant efflux systems in bacteria. Recent Pat Antiinfect Drug Discov. 2009, 41: 37-50.CrossRef
9.
Faria NA, Oliveira DC, Westh H, Monnet DL, Larsen AR, Skov R, de Lencastre H: Epidemiology of emerging methicillin-resistant Staphylococcus aureus (MRSA) in Denmark: a nationwide study in a country with low prevalence of MRSA infection. J Clin Microbiol. 2005, 43: 1836-1842. 10.1128/JCM.43.4.1836-1842.2005.CrossRefPubMedPubMedCentral
10.
11.
Khanna T, Friendship R, Dewey C, Weese SJ: Methicillin resistant Staphylococcus aureus colonization in pigs and pig farmers. Vet Microb. 2008, 128: 298-303. 10.1016/j.vetmic.2007.10.006.CrossRef
12.
van Loo I, Huijsdens X, Tiemersma E, de Neeling A, van de Sande-Bruinsma N, Beaujean D, Voss A, Kluytmans J: Emergence of methicillin-resistant Staphylococcus aureus of animal origin in humans. Emerg Infect Dis. 2007, 13: 1834-1838. 10.3201/eid1312.070384.CrossRefPubMedPubMedCentral
13.
Garcia-Alvarez L, Holden MT, Lindsay H, Webb CR, Brown DF, Curran MD, Walpole E, Brooks K, Pickard DJ, Teale C, Parkhill J, Bentley SD, Edwards GF, Girvan EK, Kearns AM, Pichon B, Hill RL, Larsen AR, Skov RL, Peacock SJ, Maskell DJ, Holmes MA: Methicillin-resistant Staphylococcus aureus with a novel mecA homologue in human and bovine populations in the UK and Denmark: a descriptive study. Lancet Infect Dis. 2011, 11: 595-603. 10.1016/S1473-3099(11)70126-8.CrossRefPubMedPubMedCentral
14.
Haran KP, Godden SM, Boxrud D, Jawahir S, Bender JB, Sreevatsan S: Prevalence and characterization of Staphylococcus aureus, including methicillin-resistant Staphylococcus aureus, isolated from bulk tank milk from Minnesota dairy farms. J Clin Microbiol. 2012, 50: 688-695. 10.1128/JCM.05214-11.CrossRefPubMedPubMedCentral
15.
Petinaki E, Spiliopoulou I: Methicillin-resistant Staphylococcus aureus among companion and food-chain animals: impact of human contacts. Clin Microbiol Infect. 2012, 18: 626-634. 10.1111/j.1469-0691.2012.03881.x.CrossRefPubMed
16.
Côté J, Caillet S, Doyon G, Dussault D, Sylvain J, Lacroix M: Antimicrobial effect of cranberry juice and extracts. Food Control. 2011, 22: 1413-1418. 10.1016/j.foodcont.2011.02.024.CrossRef
17.
Harrison JE, Oomah BD, Diarra MS, Ibarra-Alvarado C: Bioactivities of pilot-scale extracted cranberry juice and pomace. J Food Process Preserv. 2012, 10.1111/j.1745-4549.2011.00655.x.
18.
Leitão DPS, Polizello ACM, Ito IY, Spadaro ACC: Antibacterial screening of anthocyanic and proanthocyanic fractions from cranberry juice. J Med Food. 2005, 8: 36-40. 10.1089/jmf.2005.8.36.CrossRefPubMed
19.
Leusink G, Rempel H, Skura B, Berkyto M, White W, Yang Y, Rhee J-Y, Xuan SY, Chiu S, Silversides F, Fitzpatrick S, Diarra MS: Growth performance, meat quality and gut microflora of broiler chickens fed with cranberry extract. Poult Sci. 2010, 89: 1514-1523. 10.3382/ps.2009-00364.CrossRefPubMed
20.
Wu VC, Qiu X, Bushway A, Harper L: Antibacterial effects of American cranberry (Vaccinium macrocarpon) concentrate on foodborne pathogens. LWT - Food Sci Technol. 2008, 41: 1834-1841. 10.1016/j.lwt.2008.01.001.CrossRef
21.
Diarra MS, Petitclerc D, Lacasse P: Response of Staphylococcus aureus isolated from bovine mastitis to exogenous iron sources. J Dairy Sci. 2002, 85: 2141-2148. 10.3168/jds.S0022-0302(02)74292-6.CrossRefPubMed
22.
Oomah BD, Tiger N, Olson M, Balasubramanian P: Phenolics and antioxidative activities in narrow-leafed lupins (Lupinus angustifolius L.). Plant Foods Hum Nutr. 2006, 61: 91-97.CrossRefPubMed
23.
Oomah BD, Blanchard C, Balasubramanian P: Phytic acid, phytase, minerals, and antioxidant activity in Canadian dry bean (Phaseolus vulgaris L.) cultivars. J Agric Food Chem. 2008, 56: 11312-11319. 10.1021/jf801661j.CrossRefPubMed
24.
Clinical and Laboratory Standards Institute: Performance Standards for Antimicrobial Susceptibility Testing, Twenty-First Informational Supplement M100-S21. 2011, Wayne, PA, USA: CLSI
25.
Eliopoulos GM, Moellering RC: Antimicrobial combinations. Antibiotics in Laboratory Medicine. Edited by: Lorian V. 1996, Baltimore, MD: Williams and Wilkins, 330-336.
26.
Odds FC: Synergy, antagonism, and what the chequerboard puts between them. J Antimicrob Chemother. 2003, 52: 1-10.1093/jac/dkg301.CrossRefPubMed
27.
Allard M, Moisan H, Brouillette É, Gervais AL, Jacques M, Lacasse P, Diarra MS, Malouin F: Transcriptional modulation of some Staphylococcus aureus iron-regulated genes during growth in vitro and in a tissue cage model in vivo. Microb Infect. 2006, 8: 1679-1690. 10.1016/j.micinf.2006.01.022.CrossRef
28.
Pruneau M, Mitchell G, Moisan H, Dumont-Blanchette É, Jacob CL, Malouin F: Transcriptional analysis of antibiotic resistance and virulence genes in multi-resistant hospital acquired MRSA. FEMS Immunol Med Microbiol. 2011, 63: 54-64. 10.1111/j.1574-695X.2011.00830.x.CrossRefPubMed
29.
Muthaiyan A, Silverman JA, Jayaswal RK, Wilkinson BJ: Transcriptional profiling reveals that daptomycin induces the Staphylococcus aureus cell wall stress stimulon and genes responsive to membrane depolarization. Antimicrob Agents Chemother. 2008, 52: 980-990. 10.1128/AAC.01121-07.CrossRefPubMed
30.
Utaida S, Dunman PM, Macapagal D, Murphy E, Projan SJ, Singh VK, Jayaswal RK, Wilkinson BJ: Genome-wide transcriptional profiling of the response of Staphylococcus aureus to cell-wall-active antibiotics reveals a cell-wall-stress stimulon. Microbiology. 2003, 149: 2719-2732. 10.1099/mic.0.26426-0.CrossRefPubMed
31.
Mitchell G, Gattuso M, Grondin G, Marsault É, Bouarab K, Malouin F: Tomatidine inhibits replication of Staphylococcus aureus small-colony variants in cystic fibrosis airway epithelial cells. Antimicrob Agents Chemother. 2011, 55: 1937-1945. 10.1128/AAC.01468-10.CrossRefPubMedPubMedCentral
32.
Brouillette E, Grondin G, Lefebvre C, Talbot BG, Malouin F: Mouse mastitis model of infection for antimicrobial compound efficacy studies against intracellular and extracellular forms of Staphylococcus aureus. Vet Microbiol. 2004, 101: 253-262. 10.1016/j.vetmic.2004.04.008.CrossRefPubMed
33.
Borges G, Degeneve A, Mullen WP, Crozier A: Identification of flavonoid and phenolic antioxidants in black currants, blueberries, raspberries, red currants, and cranberries. J Agric Food Chem. 2010, 58: 3901-3909. 10.1021/jf902263n.CrossRefPubMed
34.
Singh AP, Wilson T, Kalk AJ, Cheong J, Vorsa N: Isolation of specific cranberry flavonoids for biological activity assessment. Food Chem. 2009, 116: 963-968. 10.1016/j.foodchem.2009.03.062.CrossRefPubMedPubMedCentral
35.
Viskelis P, Rubinskiene M, Jasutiene I, Sarkinas A, Daubaras R, Cesoniene L: Anthocyanins, antioxidative, and antimicrobial properties of American cranberry (Vaccinium macrocarpon Ait.) and their press cakes. J Food Sci. 2009, 74: C157-61. 10.1111/j.1750-3841.2009.01066.x.CrossRefPubMed
36.
37.
González-Lamothe R, Mitchell G, Gattuso M, Diarra MS, Malouin F, Bouarab K: Plant antimicrobial agents and their effects on plant and human pathogens. Int J Molecul Sci. 2009, 10: 3400-3419. 10.3390/ijms10083400.CrossRef
38.
Cimolai N, Cimolai T: The cranberry and the urinary tract. Eur J Clin Microbiol Infect Dis. 2007, 26: 767-776. 10.1007/s10096-007-0379-0.CrossRefPubMed
39.
Foo LY, Lu Y, Howell AB, Vorsa N: A-Type proanthocyanidin trimers from cranberry that inhibit adherence of uropathogenic P-fimbriated Escherichia coli. J Nat Prod. 2000, 63: 1225-1228. 10.1021/np000128u.CrossRefPubMed
40.
Howell AB: Bioactive compounds in cranberries and their role in prevention of urinary tract infections. Mol Nutr Food Res. 2007, 51: 732-737. 10.1002/mnfr.200700038.CrossRefPubMed
41.
Singh VK, Jayaswal RK, Wilkinson BJ: Cell wall-active antibiotic induced proteins of Staphylococcus aureus identified using a proteomic approach. FEMS Microbiol Lett. 2001, 199: 79-84.PubMed
42.
Kuroda M, Kuroda H, Oshima T, Takeuchi F, Mori H, Hiramatsu K: Two-component system VraSR positively modulates the regulation of cell-wall biosynthesis pathway in Staphylococcus aureus. Mol Microbiol. 2003, 49: 807-821.CrossRefPubMed
43.
Tomasz A: The Staphylococcal Cell Wall. Gram Positive Pathogens. Edited by: Fishetti VA. 2006, Washington, DC. USA: ASM Press, 443-455. 2CrossRef
44.
Su X, Howell AB, D’Souza DH: Antibacterial effects of plant-derived extracts on methicillin-resistant Staphylococcus aureus. Foodborn Pathog Dis. 2012, 9: 573-578. 10.1089/fpd.2011.1046.CrossRef
45.
Diarra MS, Rempel H, Champagne J, Masson L, Pritchard J, Topp E: Distribution of antimicrobial resistance and virulence genes in Enterococcus spp: characterization of isolates from broiler chickens. Appl Environ Microbiol. 2010, 76: 8033-8043. 10.1128/AEM.01545-10.CrossRefPubMedPubMedCentral
46.
Diarrassouba F, Diarra MS, Bach S, Delaquis P, Pritchard J, Topp E, Skura BJ: Antibiotic resistance and virulence genes in commensal Escherichia coli and Salmonella isolated from commercial broiler chicken farms. J Food Prot. 2007, 70: 1316-1327.PubMed
47.
Dahiya JP, Wilkie DC, Van Kessel AG, Drew MD: Potential strategies for controlling necrotic enteritis in broiler chickens in post-antibiotic era. Anim Feed Sci Technol. 2006, 129: 60-88. 10.1016/j.anifeedsci.2005.12.003.CrossRef
48.
Jacob J, Pescatore A:Gut Health and Organic Acids, Antimicrobial Peptides, and Botanicals as Natural Feed Additives. Organic Meat Production and Processing. Edited by: Ricke SC, Van Loo EJ, Johnson MG, O'Bryan CA. 2012, Oxford, UK: Wiley-Blackwell, 351-378. 10.1002/9781118229088.ch21.CrossRef
49.
Tow WW, Premier R, Jing H, Ajlouni S: Antioxidant and antiproliferation effects of extractable and nonextractable polyphenols isolated from apple waste using different extraction methods. J Food Sci. 2011, 76: T163-T172. 10.1111/j.1750-3841.2011.02314.x.CrossRefPubMed
50.
Puupponen-Pimiä R, Nohynek L, Meier C, Kähkönen M, Heinonen M, Hopia A, Oksman-Caldentey K: Antimicrobial properties of phenolic compounds from berries. J Appl Microbiol. 2001, 90: 494-507. 10.1046/j.1365-2672.2001.01271.x.CrossRefPubMed
51.
Taylor M, Joerger R, Palou E, López-Malo A, Avila-Sosa R, Calix-Lara T: Eds S. C. Ricke, E. J. Van Loo, M. G. Johnson. Organic Meat Production and Processing. Edited by: Ricke SC, Van Loo EJ, Johnson MG, O'Bryan CA. 2012, Oxford, UK: Wiley-Blackwell, 211-237. 10.1002/9781118229088.ch13.CrossRef
Metadata
Title
In vitro and in vivo antibacterial activities of cranberry press cake extracts alone or in combination with β-lactams against Staphylococcus aureus
Authors
Moussa S Diarra
Glenn Block
Heidi Rempel
B Dave Oomah
Judy Harrison
Jason McCallum
Simon Boulanger
Éric Brouillette
Mariza Gattuso
François Malouin
Publication date
01-12-2013
Publisher
BioMed Central
Published in
BMC Complementary Medicine and Therapies / Issue 1/2013
Electronic ISSN: 2662-7671
DOI
https://doi.org/10.1186/1472-6882-13-90

Other articles of this Issue 1/2013

BMC Complementary Medicine and Therapies 1/2013 Go to the issue

Study protocol

The efficacy and safety of a proposed herbal moisturising cream for dry skin and itch relief: a randomised, double-blind, placebo-controlled trial- study protocol

Research article

The inhibitory effect of tongxieyaofang on rats with post infectious irritable bowel syndrome through regulating colonic par-2 receptor

Research article

Effect of an office worksite-based yoga program on heart rate variability: outcomes of a randomized controlled trial

Research article

Umbelliferone β-D-galactopyranoside from Aegle marmelos (L.) corr. an ethnomedicinal plant with antidiabetic, antihyperlipidemic and antioxidative activity

Research article

Photoprotective and antioxidant effects of Rhubarb: inhibitory action on tyrosinase and tyrosine kinase activities and TNF-α, IL-1α and α-MSH production in human melanocytes

Research article

Cytotoxicity of Elaoephorbia drupifera and other Cameroonian medicinal plants against drug sensitive and multidrug resistant cancer cells